Australia markets closed

Cyclopharm Limited (CYC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.78000.0000 (0.00%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
26,339
26,339
23,219
17,705
14,676
Cost of revenue
10,256
10,256
7,441
5,042
3,963
Gross profit
16,084
16,084
15,778
12,662
10,713
Operating expenses
Research development
3,689
3,689
3,440
1,660
3,538
Selling general and administrative
16,048
16,048
13,889
11,815
10,316
Total operating expenses
26,108
26,108
23,412
19,615
19,200
Operating income or loss
-10,025
-10,025
-7,634
-6,953
-8,487
Interest expense
23.935
23.935
67.434
16.515
18.215
Total other income/expenses net
5,562
5,562
1,760
2,691
2,846
Income before tax
-4,190
-4,190
-6,030
-4,347
-5,844
Income tax expense
511.078
511.078
581.669
693.295
199.527
Income from continuing operations
-4,701
-4,701
-6,612
-5,040
-6,044
Net income
-4,701
-4,701
-6,612
-5,040
-6,044
Net income available to common shareholders
-4,701
-4,701
-6,612
-5,040
-6,044
Basic EPS
-0.08
-0.05
-0.07
-0.06
-0.08
Diluted EPS
-0.08
-0.05
-0.07
-0.06
-0.08
Basic average shares
92,007
92,664
92,179
89,690
76,591
Diluted average shares
92,007
92,664
92,179
89,690
76,591